Similar articles

• Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.

  Cuffini AM, Tullio V, Vaiani G, Carlone NA. Cuffini AM, et al. J Chemother. 1989 Jul;1(4 Suppl):178-81. J Chemother. 1989. PMID: 16312358 No abstract available.
• Preliminary results on the antibacterial and killing activity of lomefloxacin.

  Stefani S, Pellegrino MB, Mezzatesta M, Speciale AM, Caccamo F, Russo G, Nicoletti G. Stefani S, et al. J Chemother. 1989 Jul;1(4 Suppl):170-2. J Chemother. 1989. PMID: 16312355 No abstract available.
• Clinical impact of in vitro data with newer quinolones.

  Smith JT. Smith JT. J Chemother. 1989 Jul;1(4 Suppl):662-3. J Chemother. 1989. PMID: 16312581 No abstract available.
• Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

  Mitscher LA. Mitscher LA. Chem Rev. 2005 Feb;105(2):559-92. doi: 10.1021/cr030101q. Chem Rev. 2005. PMID: 15700957 Review. No abstract available.
• Concept, design, and preclinical evaluation of quinolonyl lactam antibacterials.

  Hershberger PM, Demuth TP Jr. Hershberger PM, et al. Adv Exp Med Biol. 1998;456:239-67. doi: 10.1007/978-1-4615-4897-3_13. Adv Exp Med Biol. 1998. PMID: 10549372 Review. No abstract available.